Achieving SVR Does Not Prevent From Fibrosis Progression In Patients With FCH: Results From A Large French Prospective Multicentric ANRS CO23 Cupilt Cohort

Mylene Sebagh (1) , Claire Fougerou-Leurent (2) , Georges-Philippe Pageaux (3) , Vincent Leroy (4) , Jerome Dumortier (5, 6) , Sylvie Radenne (7) , Christine Sylvain (8) , Pascal Lebray (9) , Pauline Houssel-Debry (10) , Carole Cagnot , Emilie Rossignol (2) , Helene Danjou (2) , Aurelie Veislinger (2) , Didier Samuel (11, 12) , Jean-Charles Duclos-Vallée (11, 13) , Audrey Coilly (11, 12)

1 AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre)
2 CIC - Centre d'Investigation Clinique [Rennes]
3 CHU - Hôpital Lapeyronie [Montpellier]
4 CHU Grenoble
5 CHU de Lyon
6 UCBL - Université Claude Bernard Lyon 1
7 Hôpital de la Croix-Rousse [CHU - HCL]
8 CHU Poitiers - Centre hospitalier universitaire de Poitiers
9 CHU Paris
10 CHU Pontchaillou [Rennes]
11 Hôpital Paul Brousse
12 Physiopathologie et traitement des maladies du foie
13 DHU Hepatinov

Domains: Life Sciences [q-bio]

Mylene Sebagh, Claire Fougerou-Leurent, Georges-Philippe Pageaux, Vincent Leroy, Jerome Dumortier, et al.. Achieving SVR Does Not Prevent From Fibrosis Progression In Patients With FCH: Results From A Large French Prospective Multicentric ANRS CO23 Cupilt Cohort. Hepatology, 2017, 66, pp.872A-872A. ⟨hal-01684629⟩